Its cardiac deleterious effects are characterized by an increase in fibrous tissue that increases myocardial stiffness and contributes to subclinical left ventricular diastolic dysfunction ( LVDD ) and heart failure with preserved ejection fraction in patients with MS. In addition to lifestyle counseling ( LC ) , metformin treatment may attenuate or even reverse diastolic dysfunction in these patients .